glp 1 aafp Glucagon-Like Peptide-1 Receptor Agonists for People With Chronic Kidney Disease and Diabetes glp 1 aafp Are Serious

Selenium supplementation, particularly in individuals with low Se status, may lead to a reduction in the size of the goiter

In the course of clinical treatment, the impact of diabetes on bone health is often overlooked or underestimated

Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G et al (2022c) COVID-19 and diabetes: will novel drugs for diabetes help in COVID-19

The study found that when comparing the neuroprotective abilities of two diabetes medications metformin and glucagon-like peptide-1 receptor agonists (GLP-1 agonists) participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin